Baird Medical Corp (BDMD) - Aggregate Business Assets

Baird Medical Investment (BDMD) is developing a Chinese production network for ablation systems, expanding its US presence following FDA certification. The business relies on stable demand, although government procurement may impact cash flows. This chart on GURU.Markets reflecting value dynamics captures total assets at 75.41. Growth is supported by a partnership with Baird Medical to create safe, minimally invasive techniques for tumor removal.

Patent protection for microwave ablation systems and stringent FDA requirements create a sustainable market moat for Baird Medical (BDMD), necessitating significant capital expenditures. By analyzing the total assets value on GURU.Markets, an investor can see the sum of resources and liabilities reverse-calculated via ROA, which allows for an assessment of the actual scale of business expansion and the risk of excessive debt leverage.